YU20200A - Postupak sinteze hloropurinskih intermedijera - Google Patents

Postupak sinteze hloropurinskih intermedijera

Info

Publication number
YU20200A
YU20200A YU20200A YU20200A YU20200A YU 20200 A YU20200 A YU 20200A YU 20200 A YU20200 A YU 20200A YU 20200 A YU20200 A YU 20200A YU 20200 A YU20200 A YU 20200A
Authority
YU
Yugoslavia
Prior art keywords
formula
synthesis
situ
compound
chloropurine
Prior art date
Application number
YU20200A
Other languages
English (en)
Inventor
Martin Francis Jones
Christopher John Wallis
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of YU20200A publication Critical patent/YU20200A/sh
Publication of RS49710B publication Critical patent/RS49710B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Ovaj pronalazak se odnosi na postupak dobijanja karbocikličnog purinskog nukleozida analognog formuli (I), njegove soli i njegovih farmaceutski prihvatljivih derivata, koji se sastoji od hidrolize jedinjenja formule (IV) gde je P zaštitna grupa, u prisustvu kiseline, kondenzovanja proizvoda formule (V), nastalog in situ u prisustvu baze, sa jedinjenjem formule (VI), nakon čega sledi in situ zatvaranje prstena u dobijenom intermedijaru.[The present invention relates to a process for the preparation of a carbocyclic purine nucleoside analogue of formula (I), its salts and pharmaceutically acceptable derivatives thereof which comprises hydrolysing a compound of formula (IV) wherein P is a protecting group, in the presence of an acid, condensing the product of formula (V) formed i(in situ) in the presence of a base with a compound of formula (VI) followed by i(in situ) ring closure of the resulting intermediate.
YUP-202/00A 1997-10-14 1998-10-14 Postupak sinteze hloropurinskih intermedijara RS49710B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721780.6A GB9721780D0 (en) 1997-10-14 1997-10-14 Process for the synthesis of chloropurine intermediates

Publications (2)

Publication Number Publication Date
YU20200A true YU20200A (sh) 2003-02-28
RS49710B RS49710B (sr) 2007-12-31

Family

ID=10820547

Country Status (44)

Country Link
US (1) US6646125B1 (sh)
EP (1) EP1023292B1 (sh)
JP (1) JP4531250B2 (sh)
KR (1) KR100543845B1 (sh)
CN (1) CN1160354C (sh)
AP (1) AP1182A (sh)
AR (1) AR014921A1 (sh)
AT (1) ATE249461T1 (sh)
AU (1) AU738462B2 (sh)
BG (1) BG64597B1 (sh)
BR (1) BR9813048B1 (sh)
CA (1) CA2306958C (sh)
CO (1) CO4980899A1 (sh)
CZ (1) CZ294482B6 (sh)
DE (1) DE69818084T2 (sh)
DK (1) DK1023292T3 (sh)
EA (1) EA003183B1 (sh)
EE (1) EE04059B1 (sh)
EG (1) EG21730A (sh)
ES (1) ES2205553T3 (sh)
GB (1) GB9721780D0 (sh)
GE (1) GEP20022679B (sh)
HK (1) HK1027807A1 (sh)
HR (1) HRP20000216B1 (sh)
HU (1) HUP0003984A3 (sh)
ID (1) ID24927A (sh)
IL (1) IL135323A (sh)
IN (1) IN184590B (sh)
IS (1) IS2195B (sh)
MA (1) MA24676A1 (sh)
MY (1) MY127470A (sh)
NO (1) NO325030B1 (sh)
NZ (1) NZ503679A (sh)
OA (1) OA11370A (sh)
PE (1) PE121899A1 (sh)
PL (1) PL188477B1 (sh)
PT (1) PT1023292E (sh)
RS (1) RS49710B (sh)
SK (1) SK285331B6 (sh)
TR (1) TR200000976T2 (sh)
TW (1) TW436488B (sh)
UA (1) UA54550C2 (sh)
WO (1) WO1999019327A1 (sh)
ZA (1) ZA989338B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298102B6 (cs) 1997-11-27 2007-06-20 Lonza Ag Zpusob výroby aminoalkoholu
FR2849030A1 (fr) * 2002-12-20 2004-06-25 Isochem Sa Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides
GB0320738D0 (en) * 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
CN100465174C (zh) * 2006-06-13 2009-03-04 中国科学院上海有机化学研究所 制备光学纯阿巴卡韦的方法
KR101109476B1 (ko) * 2009-06-26 2012-01-31 현대제철 주식회사 실린더 교체용 지그장치
ES2688925T3 (es) 2010-01-27 2018-11-07 Viiv Healthcare Company Tratamiento antiviral
CN104672239A (zh) * 2013-11-26 2015-06-03 上海迪赛诺化学制药有限公司 一种采用一锅法制备阿巴卡韦式v中间体的工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS6175A (ja) * 1984-03-06 1986-01-06 ブリストル−マイア−ズ コムパニ− 神経弛緩剤、1‐フルオロフェニルブチル‐4‐(5‐ハロ‐2‐ピリミジニル)ピペラジン誘導体
YU47791B (sr) 1988-01-20 1996-01-09 Regents Of The University Of Minnesota Postupak za dobijanje dideoksihidrokar-bocikličnih nukleozida
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5329008A (en) 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
SK285229B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby derivátov (1R,4S)- alebo (1S,4R)-1-amino-4- (hydroxymetyl)-2-cyklopenténu a enantioméru (1R,4S)-N-butyryl-1- amino-4-(hydroxymetyl)-2-cyklopenténu

Also Published As

Publication number Publication date
IN184590B (sh) 2000-09-09
CZ20001367A3 (cs) 2000-10-11
US6646125B1 (en) 2003-11-11
CN1160354C (zh) 2004-08-04
MY127470A (en) 2006-12-29
NO20001896L (no) 2000-06-13
NO325030B1 (no) 2008-01-21
CO4980899A1 (es) 2000-11-27
DK1023292T3 (da) 2003-11-10
TR200000976T2 (tr) 2000-11-21
EA003183B1 (ru) 2003-02-27
ZA989338B (en) 2000-04-13
OA11370A (en) 2004-01-27
AP1182A (en) 2003-06-18
CN1281457A (zh) 2001-01-24
ATE249461T1 (de) 2003-09-15
EG21730A (en) 2002-02-27
IL135323A (en) 2004-07-25
BG64597B1 (bg) 2005-08-31
WO1999019327A1 (en) 1999-04-22
GEP20022679B (en) 2002-04-25
BR9813048B1 (pt) 2010-07-13
PT1023292E (pt) 2004-02-27
EP1023292B1 (en) 2003-09-10
EA200000318A1 (ru) 2000-12-25
AR014921A1 (es) 2001-04-11
TW436488B (en) 2001-05-28
PE121899A1 (es) 1999-12-20
GB9721780D0 (en) 1997-12-10
RS49710B (sr) 2007-12-31
AU738462B2 (en) 2001-09-20
MA24676A1 (fr) 1999-07-01
CA2306958A1 (en) 1999-04-22
KR100543845B1 (ko) 2006-01-23
BG104352A (en) 2001-02-28
NO20001896D0 (no) 2000-04-12
ES2205553T3 (es) 2004-05-01
PL188477B1 (pl) 2005-02-28
EE200000162A (et) 2001-04-16
ID24927A (id) 2000-08-31
HUP0003984A2 (hu) 2001-04-28
DE69818084D1 (de) 2003-10-16
BR9813048A (pt) 2000-08-15
IS2195B (is) 2007-01-15
AU9547698A (en) 1999-05-03
NZ503679A (en) 2002-09-27
PL339904A1 (en) 2001-01-15
EE04059B1 (et) 2003-06-16
IL135323A0 (en) 2001-05-20
SK285331B6 (sk) 2006-11-03
CA2306958C (en) 2007-09-04
DE69818084T2 (de) 2004-07-15
HRP20000216A2 (en) 2000-08-31
JP2001519432A (ja) 2001-10-23
EP1023292A1 (en) 2000-08-02
HUP0003984A3 (en) 2002-12-28
AP2000001790A0 (en) 2000-06-30
HRP20000216B1 (en) 2002-08-31
IS5423A (is) 2000-03-28
SK5362000A3 (en) 2001-03-12
HK1027807A1 (en) 2001-01-23
CZ294482B6 (cs) 2005-01-12
JP4531250B2 (ja) 2010-08-25
UA54550C2 (uk) 2003-03-17
KR20010015744A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
TW262474B (sh)
MY107319A (en) Process for the preparation of cyclic amino acids, as well as intermediates.
EA199700124A1 (ru) Производные гуанина
CO4750664A1 (es) Marcfortinas y parahercuamidas antiparasitarias
ES8801237A1 (es) Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina
DK0832063T3 (da) Vitamin D-derivater med substituenter på C-25, fremgangsmåde til deres fremstilling, mellemprodukter samt deres anvendelse
YU20200A (sh) Postupak sinteze hloropurinskih intermedijera
BG107050A (en) Method for the preparation of citalopram
EP0930292A4 (en) METHOD FOR PRODUCING BETA-AMINO-ALPHA-HYDROXYCARBONIC ACID DERIVATIVES
AU3420099A (en) Process for the production of purine derivatives and intermediates therefor
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
DE60331334D1 (de) VERFAHREN ZUR HERSTELLUNG VON 9-i4-ACETOXY-3-(ACETOXYMETHYL)BUT-1-YL -2-AMINOPURIN
EG20562A (en) Process for preparing glutaramide derivatives
HUP0000726A2 (hu) Eljárás flukonazol előállítására
UA41340C2 (uk) Похідні циклогексанкарбонової кислоти, суміш їх ізомерів або окремі ізомери і фізіологічно прийнятні солі і фармацевтична композиція з активністю, що гальмує ферментний комплекс глюкоза-6-фосфатази
HU905025D0 (en) Process for producing new compounds and pharmaceutical preparatives against viruses
CA2277151A1 (en) Synthesis of acyclic nucleoside derivatives
TNSN99060A1 (fr) Procede pour la synthese d'intermediaires chloropurine
HUP0102729A2 (hu) Karbapenem-3-karbonsavak C-2 S/O- és S/N- (formaldehid-acetál)-származékai, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
FI956247A (fi) Uusia menetelmiä (S)-4-amino-hepta-5,6-dieenihappo ja sen välituotteiden valmistamiseksi
MX9705481A (es) Farmacos.
EP1197489A4 (en) PYRIMIDINE DERIVATIVES AND THEIR PREPARATION PROCESS
AU7919700A (en) Method for the production of cyanoacetic acid esters
PA8470601A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina